These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27758945)

  • 1. Uric Acid Therapy Prevents Early Ischemic Stroke Progression: A Tertiary Analysis of the URICO-ICTUS Trial (Efficacy Study of Combined Treatment With Uric Acid and r-tPA in Acute Ischemic Stroke).
    Amaro S; Laredo C; Renú A; Llull L; Rudilosso S; Obach V; Urra X; Planas AM; Chamorro Á;
    Stroke; 2016 Nov; 47(11):2874-2876. PubMed ID: 27758945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of Collaterals for the Success of Neuroprotective Therapies in Acute Ischemic Stroke: Insights from the Randomized URICO-ICTUS Trial.
    Amaro S; Renú A; Laredo C; Castellanos M; Arenillas JF; Llull L; Rudilloso S; Urra X; Obach V; Chamorro Á;
    Cerebrovasc Dis; 2019; 47(3-4):171-177. PubMed ID: 31163434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uric Acid Therapy Improves Clinical Outcome in Women With Acute Ischemic Stroke.
    Llull L; Laredo C; Renú A; Pérez B; Vila E; Obach V; Urra X; Planas A; Amaro S; Chamorro Á
    Stroke; 2015 Aug; 46(8):2162-7. PubMed ID: 26159792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial.
    Chamorro A; Amaro S; Castellanos M; Segura T; Arenillas J; Martí-Fábregas J; Gállego J; Krupinski J; Gomis M; Cánovas D; Carné X; Deulofeu R; Román LS; Oleaga L; Torres F; Planas AM;
    Lancet Neurol; 2014 May; 13(5):453-60. PubMed ID: 24703208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4.5 h of onset of symptoms.
    Amaro S; Cánovas D; Castellanos M; Gállego J; Martí-Fèbregas J; Segura T; Chamorro A
    Int J Stroke; 2010 Aug; 5(4):325-8. PubMed ID: 20636718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Thrombolysis and Statins in Acute Stroke Is Safe: Results of the STARS Randomized Trial (Stroke Treatment With Acute Reperfusion and Simvastatin).
    Montaner J; Bustamante A; García-Matas S; Martínez-Zabaleta M; Jiménez C; de la Torre J; Rubio FR; Segura T; Masjuán J; Cánovas D; Freijo M; Delgado-Mederos R; Tejada J; Lago A; Bravo Y; Corbeto N; Giralt D; Vives-Pastor B; de Arce A; Moniche F; Delgado P; Ribó M;
    Stroke; 2016 Nov; 47(11):2870-2873. PubMed ID: 27758944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke.
    Amaro S; Soy D; Obach V; Cervera A; Planas AM; Chamorro A
    Stroke; 2007 Jul; 38(7):2173-5. PubMed ID: 17525395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke).
    Barreto AD; Ford GA; Shen L; Pedroza C; Tyson J; Cai C; Rahbar MH; Grotta JC;
    Stroke; 2017 Jun; 48(6):1608-1616. PubMed ID: 28507269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid improves glucose-driven oxidative stress in human ischemic stroke.
    Amaro S; Llull L; Renú A; Laredo C; Perez B; Vila E; Torres F; Planas AM; Chamorro Á
    Ann Neurol; 2015 May; 77(5):775-83. PubMed ID: 25627874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of Uric Acid in the Emergency Treatment of Acute Ischemic Stroke.
    Llull L; Amaro S; Chamorro Á
    Curr Neurol Neurosci Rep; 2016 Jan; 16(1):4. PubMed ID: 26711273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy.
    Chamorro Á; Amaro S; Castellanos M; Gomis M; Urra X; Blasco J; Arenillas JF; Román LS; Muñoz R; Macho J; Cánovas D; Marti-Fabregas J; Leira EC; Planas AM;
    Int J Stroke; 2017 Jun; 12(4):377-382. PubMed ID: 28345429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Thrombus Length on Outcomes After Intra-Arterial Aspiration Thrombectomy in the THERAPY Trial.
    Yoo AJ; Khatri P; Mocco J; Zaidat OO; Gupta R; Frei D; Lopes D; Shownkeen H; Berkhemer OA; Meyer D; Hak SS; Kuo SS; Buell H; Bose A; Sit SP; von Kummer R;
    Stroke; 2017 Jul; 48(7):1895-1900. PubMed ID: 28596447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
    Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
    Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial.
    Zhu Z; Fu Y; Tian D; Sun N; Han W; Chang G; Dong Y; Xu X; Liu Q; Huang D; Shi FD
    Circulation; 2015 Sep; 132(12):1104-1112. PubMed ID: 26202811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.
    Parsons M; Spratt N; Bivard A; Campbell B; Chung K; Miteff F; O'Brien B; Bladin C; McElduff P; Allen C; Bateman G; Donnan G; Davis S; Levi C
    N Engl J Med; 2012 Mar; 366(12):1099-107. PubMed ID: 22435369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of leukoaraiosis, leptomeningeal collaterals, and clinical outcomes after intra-arterial therapy in patients with acute ischemic stroke.
    Giurgiutiu DV; Yoo AJ; Fitzpatrick K; Chaudhry Z; Leslie-Mazwi T; Schwamm LH; Rost NS
    J Neurointerv Surg; 2015 May; 7(5):326-30. PubMed ID: 24721756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
    Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
    Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NXY-059 for acute ischemic stroke.
    Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
    N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theophylline as an Add-On to Thrombolytic Therapy in Acute Ischemic Stroke: A Randomized Placebo-Controlled Trial.
    Modrau B; Andersen G; Mikkelsen IK; Nielsen A; Hansen MB; Johansen MB; Eskildsen HW; Povlsen JP; Yavarian Y; Mouridsen K; Østergaard L; Bach FW; Hjort N
    Stroke; 2020 Jul; 51(7):1983-1990. PubMed ID: 32568651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.